Screener
Tango Therapeutics TNGX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
FAQ
- What is Tango Therapeutics's net margin?
- Tango Therapeutics (TNGX) reported net margin of -188.2% in Q1 2026.
- How has Tango Therapeutics's net margin changed year-over-year?
- Tango Therapeutics's net margin increased by 41.7% year-over-year, from -322.7% to -188.2%.
- What is the long-term trend for Tango Therapeutics's net margin?
- Over 4 years (2021 to 2025), Tango Therapeutics's net margin has grown at a 0.9% compound annual growth rate (CAGR), from -157.2% to -162.9%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Tango Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude